Published in Pediatrics on February 01, 2004
A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry (2010) 5.00
The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet Gynecol (2009) 3.52
The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry (2009) 2.01
Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology (2006) 1.83
Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta Psychiatr Scand (2012) 1.75
Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin Pharmacol Ther (2009) 1.71
Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors. Early Hum Dev (2012) 1.52
The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month. Am J Psychiatry (2015) 1.45
Prevalence and patterns of antidepressant drug use during pregnancy. Eur J Clin Pharmacol (2006) 1.43
Depression during pregnancy. Can Fam Physician (2005) 1.35
Prenatal mood disturbance predicts sleep problems in infancy and toddlerhood. Early Hum Dev (2006) 1.30
Depression during pregnancy. Can Fam Physician (2005) 1.29
Perinatal depression: treatment options and dilemmas. J Psychiatry Neurosci (2008) 1.22
Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities. PLoS One (2008) 1.10
Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development. Psychopharmacology (Berl) (2011) 1.08
Selective serotonin reuptake inhibitors affect neurobehavioral development in the human fetus. Neuropsychopharmacology (2011) 1.05
Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment. Depress Anxiety (2011) 0.96
Annual Research Review: New frontiers in developmental neuropharmacology: can long-term therapeutic effects of drugs be optimized through carefully timed early intervention? J Child Psychol Psychiatry (2011) 0.95
The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring. Front Cell Neurosci (2013) 0.94
Psychopharmacologic management of opioid-dependent women during pregnancy. Am J Addict (2009) 0.92
Genetic and pharmacological manipulations of the serotonergic system in early life: neurodevelopmental underpinnings of autism-related behavior. Front Cell Neurosci (2013) 0.92
Evidence of a role for the 5-HTTLPR genotype in the modulation of motor response to antidepressant treatment. Psychopharmacology (Berl) (2004) 0.90
Neonatal exposure to citalopram selectively alters the expression of the serotonin transporter in the hippocampus: dose-dependent effects. Anat Rec (Hoboken) (2010) 0.90
Pregnancy and delivery while receiving vagus nerve stimulation for the treatment of major depression: a case report. Ann Gen Psychiatry (2005) 0.90
The mothers, Omega-3 and mental health study. BMC Pregnancy Childbirth (2011) 0.89
Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis. PLoS One (2014) 0.89
The use of psychotropic medication during pregnancy: how about the newborn? Neuropsychiatr Dis Treat (2013) 0.89
Developmental model of depression applied to prenatal depression: role of present and past life events, past emotional disorders and pregnancy stress. PLoS One (2010) 0.88
Selective serotonin reuptake inhibitors in human pregnancy: to treat or not to treat? Obstet Gynecol Int (2011) 0.88
Sertraline exposure leads to small left heart syndrome in adult mice. Pediatr Res (2012) 0.85
Evidence that the deficit in sexual behavior in adult rats neonatally exposed to citalopram is a consequence of 5-HT1 receptor stimulation during development. Brain Res (2006) 0.85
Antidepressant use in pregnant and postpartum women. Annu Rev Clin Psychol (2013) 0.85
A "bottom-up" approach to aetiological research in autism spectrum disorders. Front Hum Neurosci (2013) 0.84
Neurodevelopmental outcome for offspring of women treated for antenatal depression: a systematic review. Arch Womens Ment Health (2014) 0.83
Neonatal exposure to fluoxetine and fluvoxamine alteres spine density in mouse hippocampal CA1 pyramidal neurons. Int J Clin Exp Pathol (2011) 0.83
Neonatal effects of exposure to selective serotonin reuptake inhibitors during pregnancy. Arch Dis Child Fetal Neonatal Ed (2006) 0.83
Developmental changes in serotonin signaling: Implications for early brain function, behavior and adaptation. Neuroscience (2016) 0.82
Early neurological outcome of young infants exposed to selective serotonin reuptake inhibitors during pregnancy: results from the observational SMOK study. PLoS One (2013) 0.81
Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors: Implications for Sex Differences, Early Stress and Prenatal SSRI Exposure. Curr Neuropharmacol (2011) 0.81
Depression during pregnancy: views on antidepressant use and information sources of general practitioners and pharmacists. BMC Health Serv Res (2009) 0.80
Mood disorders and their pharmacological treatment during pregnancy: is the future child affected? Pediatr Res (2011) 0.80
Prenatal antidepressant exposure: clinical and preclinical findings. Pharmacol Rev (2014) 0.79
Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapy. Neonatology (2013) 0.78
Early-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats. Neuroscience (2014) 0.78
Nutritional implications of observed neurobehavioral disturbances and reduced gestation length in infants of mothers using selective serotonin reuptake inhibitors during pregnancy. Pediatrics (2004) 0.75
Maternal Use of Selective Serotonin Reuptake Inhibitors and Lengthening of the Umbilical Cord: Indirect Evidence of Increased Foetal Activity-A Retrospective Cohort Study. PLoS One (2016) 0.75
Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research. Int J Dev Neurosci (2016) 0.75
Findings from selective serotonin reuptake inhibitor-exposed neonates should be interpreted with caution. Pediatrics (2004) 0.75
Behavioral and developmental changes in rats with prenatal exposure of mirtazapine. Sci Pharm (2010) 0.75
Nonepileptic motor phenomena in the neonate. Paediatr Child Health (2008) 0.75
Fine Motor Differences and Prenatal Serotonin Reuptake Inhibitors Exposure. J Pediatr (2016) 0.75
Concerns regarding antidepressant drug use during pregnancy. J Psychiatry Neurosci (2006) 0.75
Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise. Psychopharmacology (Berl) (2013) 0.75